sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has released its Form 8.3 concerning its interests in Mural Oncology plc. As of August 18, 2025, Vanguard held 771,747 ordinary shares in Mural Oncology, representing a 4.47% stake. This disclosure aligns with Rule 8.3 of the Irish Takeover Panel Act, 1997, and Takeover Rules, 2022.
The document specifies that Vanguard sold 48 of these shares at $1.82 each. No cash-settled or stock-settled derivatives were listed in the form. The report indicates there are no agreements or commitments influencing the deal's outcome. Notably, there are also no attachments or supplemental forms included in the disclosure.
This statement provides important transparency for stakeholders regarding Vanguard's position in Mural Oncology amid potential takeover discussions.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.